• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

SYNERON RECEIVES FDA APPROVAL

Syneron Medical Ltd. announced the FDA granted 510K marketing clearance to its Polaris LV system for vascular lesion treatment.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
Related Content
BioLab Tests Innovative Wound Care Product
January 13th 2025

BioLab Tests Innovative Wound Care Product

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Identifying Ancestry-Specific Clinical End Points in Diverse Trials
January 13th 2025

Identifying Ancestry-Specific Clinical End Points in Diverse Trials

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Weekly Roundup: January 5 – 11
January 12th 2025

The Weekly Roundup: January 5 – 11

Top 5 Articles of the Week: January 5-10
January 11th 2025

Top 5 Articles of the Week: January 5-10

© 2025 MJH Life Sciences

All rights reserved.